Trolamine

Trolamine

SCHEMBL9113868

C.OCCN(CCO)CCO

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.44
KDM4E B2RXH2 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALOX15 P16050 1/20 0.39
HPGD P15428 2/20 0.36
MAPK1 P28482 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
TSHR P16473 1/20 0.33
ALDH1A1 P00352 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trolamine SCHEMBL434089 0.95 MAPT (0.47) MAPTKDM4ESMN1; SMN2ALOX15HPGD
Trolamine SCHEMBL4748243 0.95 MAPT (0.47) MAPTKDM4ESMN1; SMN2ALOX15HPGD
Trolamine SCHEMBL15845959 0.95 MAPT (0.47) MAPTKDM4ESMN1; SMN2ALOX15HPGD
Trolamine SCHEMBL1146 0.95 MAPT (0.47) MAPTKDM4ESMN1; SMN2ALOX15HPGD
SCHEMBL23528233 0.91 MAPT (0.46) MAPTKDM4ESMN1; SMN2ALOX15HPGD
Trolamine SCHEMBL5862137 0.91 MAPT (0.44) MAPTKDM4ESMN1; SMN2ALOX15HPGD
Trolamine SCHEMBL9716114 0.91 TSHR (0.46) MAPTKDM4ESMN1; SMN2ALOX15HPGD
Trolamine SCHEMBL5934922 0.91 MAPT (0.44) MAPTKDM4ESMN1; SMN2ALOX15HPGD
Trolamine SCHEMBL565435 0.91 MAPT (0.44) MAPTKDM4ESMN1; SMN2ALOX15HPGD
SCHEMBL2157617 0.91 MAPT (0.46) MAPTKDM4ESMN1; SMN2ALOX15HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142938-A1 Non-halogen activating agent used as flux HUNAN ASTAR BIOTECHNOLOGY LTD (CN) 2012-06-07 US claimed
CN-106702800-B A method of straw lignin and hemicellulose are removed with proton type ionic liquid 中国科学院过程工程研究所 2019-02-26 CN disclosed
CN-107530244-A Concentrated type personal cleaning compositions and method 宝洁公司 2018-01-02 CN disclosed
CN-107530245-A Concentrated type personal cleaning compositions and purposes 宝洁公司 2018-01-02 CN disclosed
CN-107530247-A Concentrated type personal cleaning compositions 宝洁公司 2018-01-02 CN disclosed
CN-107530248-A CONCENTRATED PERSONAL CLEANSING COMPOSITIONS AND METHODS 宝洁公司 2018-01-02 CN disclosed
CN-107530246-A Concentrated type personal cleaning compositions and method 宝洁公司 2018-01-02 CN disclosed
CN-106702800-A Method for removing straw lignin and hemicellulose by using protic ionic liquid 中国科学院过程工程研究所 2017-05-24 CN disclosed
CN-104388966-A Normal temperature water-based antirust cleaning agent TAN JIANZHONG 2015-03-04 CN disclosed
US-8853417-B2 Non-halogen activating agent used as flux HUNAN ASTAR BIOTECHNOLOGY LTD. (CN) 2014-10-07 US disclosed
US-20120142938-A1 Non-halogen activating agent used as flux HUNAN ASTAR BIOTECHNOLOGY LTD (CN) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142938-A1 Non-halogen activating agent used as flux FOS, SLC7A1, FOSB MAPT 4794/4885KDM4E 3346/4885SMN1; SMN2 4419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.